Cargando…

Gefitinib-induced hemorrhagic cystitis and inflammatory contracted bladder in a patient with advanced lung adenocarcinoma harboring compound epidermal growth factor receptor G719S and S768I missense mutations: a case report

BACKGROUND: Numerous clinical studies have established the efficacy and safety of gefitinib for treating patients with epidermal growth factor receptor (EGFR)-mutant lung cancer. Gefitinib-induced urinary system-related adverse reactions are rare but may lead to discontinuation of gefitinib. CASE DE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bai, Xueli, Cheng, Jiande, Zhao, Lifen, Cheng, Mengyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372651/ https://www.ncbi.nlm.nih.gov/pubmed/35965829 http://dx.doi.org/10.21037/atm-22-3233

Ejemplares similares

Association between gefitinib and hemorrhagic cystitis and severely contracted bladder: a case report
por: Arakawa, Maki, et al.
Publicado: (2010)

The Effectiveness of Afatinib in a Patient with Advanced Lung Adenocarcinoma Harboring Rare G719X and S768I Mutations
por: Watanabe, Masahiro, et al.
Publicado: (2017)

Successful afatinib rechallenge in a patient with non‐small cell lung cancer harboring EGFR G719C and S768I mutations
por: Masuda, Tomomi, et al.
Publicado: (2020)

Response to: Successful afatinib rechallenge in a patient with non‐small cell lung cancer harboring EGFR G719C and S768I mutations
por: Citarella, Fabrizio, et al.
Publicado: (2021)

Osimertinib Treatment Was Unsuccessful for Lung Adenocarcinoma with G719S, S768I, and T790M Mutations
por: Nasu, Shingo, et al.
Publicado: (2018)

Exploring the conformational dynamics and thermodynamics of EGFR S768I and G719X + S768I mutations in non-small cell lung cancer: An in silico approaches
por: Wang, Jun-Ling, et al.
Publicado: (2023)

Afatinib in Untreated Stage IIIB/IV Lung Adenocarcinoma with Major Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations (G719X/L861Q/S768I): A Multicenter Observational Study in Taiwan
por: Hsu, Ping-Chih, et al.
Publicado: (2023)

A rare case of double primary lung adenocarcinomas with uncommon complex EGFR G719X and S768I mutations and pleomorphic carcinoma
por: Morimoto, Toshiki, et al.
Publicado: (2023)

Unique characteristics of G719X and S768I compound double mutations of epidermal growth factor receptor (EGFR) gene in lung cancer of coal-producing areas of East Yunnan in Southwestern China
por: Wang, Jun-Ling, et al.
Publicado: (2022)

Characterisation of protein-truncating and missense variants in PALB2 in 15 768 women from Malaysia and Singapore
por: Ng, Pei Sze, et al.
Publicado: (2022)

Successful treatment of a patient with NSCLC carrying uncommon compound EGFR G719X and S768I mutations using osimertinib: A case report
por: Cai, Yangyang, et al.
Publicado: (2020)

A single-arm, multicenter, phase II trial of osimertinib in patients with epidermal growth factor receptor exon 18 G719X, exon 20 S768I, or exon 21 L861Q mutations
por: Villaruz, L.C., et al.
Publicado: (2023)

Recurrent hemorrhagic shock from hemorrhagic cystitis due to neurogenic bladder
por: Isobe, Teruki, et al.
Publicado: (2021)

768. Gaining Compliance-Getting Results
por: Staton, Sharon, et al.
Publicado: (2021)

Dabigatran Induced Hemorrhagic Cystitis in a Patient with Painful Bladder Syndrome
por: Otteno, Helen, et al.
Publicado: (2014)

Equine idiopathic hemorrhagic cystitis: Clinical features and comparison with bladder neoplasia
por: Smith, Fauna L., et al.
Publicado: (2018)

Effectiveness of Gefitinib against Non–Small-Cell Lung Cancer with the Uncommon EGFR Mutations G719X and L861Q
por: Watanabe, Satoshi, et al.
Publicado: (2014)

BYL719 reverses gefitinib-resistance induced by PI3K/AKT activation in non-small cell lung cancer cells
por: Yu, Yaya, et al.
Publicado: (2023)

Effectiveness of afatinib after ineffectiveness of gefitinib in an advanced lung adenocarcinoma patient with a single EGFR exon 20 S768I mutation: a case report
por: Duan, Hua, et al.
Publicado: (2018)

Poster Sessions 555 - 719
Publicado: (2003)

Does repeated hydrodistension with transurethral fulguration for interstitial cystitis with Hunner’s lesion cause bladder contraction?
por: Tomoe, Hikaru, et al.
Publicado: (2019)

ZNF768 links oncogenic RAS to cellular senescence
por: Villot, Romain, et al.
Publicado: (2021)

Case Report: The effective treatment of patients in advanced no-small cell lung cancer patients with EGFR G719X/S768I/L861Q and acquired MET amplification: A case series and literature review
por: Zhao, Yun, et al.
Publicado: (2023)

Norms of Interocular Circumpapillary Retinal Nerve Fiber Layer Thickness Differences at 768 Retinal Locations
por: Baniasadi, Neda, et al.
Publicado: (2020)

Urinary bladder xanthomatous cystitis
por: Shah, Shrenik J., et al.
Publicado: (2017)

Acquired Gefitinib-Resistant Mutation of EGFR in a Chemonaive Lung Adenocarcinoma Harboring Gefitinib-Sensitive Mutation L858R
por: Gow, Chien-Hung, et al.
Publicado: (2005)

Lung adenocarcinoma harboring L858R and T790M mutations in epidermal growth factor receptor, with poor response to gefitinib: A case report
por: WANG, YUE FENG, et al.
Publicado: (2014)

Prolonged response to first‐generation tyrosine kinase inhibitor in a metastatic non‐small cell lung cancer harbouring complex G719X and S768I mutations: A case report from Vietnam and literature review
por: Do, Kien Hung, et al.
Publicado: (2023)

Ectopic prostate tissue at the bladder trigone accompanied by cystitis glandularis and hemorrhage detected by multiparametric MRI
por: Sun, Meng-Ya, et al.
Publicado: (2022)

Exam ref 70-768 developing SQL data models
por: Varga, Stacia
Publicado: (2017)

768. Epidemiological and Clinical Profile of Miliary Tuberculosis in Southern of Tunisia
por: Jemaa, Maissa Ben, et al.
Publicado: (2018)

ZNF768: controlling cellular senescence and proliferation with ten fingers
por: Villot, Romain, et al.
Publicado: (2021)

Hemorrhagic cystitis: A challenge to the urologist
por: Manikandan, R., et al.
Publicado: (2010)

Penicillin G-induced hemorrhagic cystitis
por: Kaya, Engin, et al.
Publicado: (2015)

Hepatocyte growth factor reduces sensitivity to the epidermal growth factor receptor-tyrosine kinase inhibitor, gefitinib, in lung adenocarcinoma cells harboring wild-type EGFR
por: Yang, Hua, et al.
Publicado: (2016)

Hemorrhagic Cystitis Requiring Bladder Irrigation is Associated with Poor Mortality in Hospitalized Stem Cell Transplant Patients
por: Raup, Valary T., et al.
Publicado: (2015)

Gefitinib for Epidermal Growth Factor Receptor Activated Osteoarthritis Subpopulation Treatment
por: Sun, Heng, et al.
Publicado: (2018)

768. Digital Patient Education: A Tool to Improve Awareness of CMV
por: Larkin, Amy, et al.
Publicado: (2023)

The Overlap of Interstitial Cystitis/Painful Bladder Syndrome and Overactive Bladder
por: Chung, Maurice K., et al.
Publicado: (2010)

Increased bladder permeability in interstitial cystitis/painful bladder syndrome
por: Hurst, Robert E., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_u8jhj69co26osd2i7pglas8r5a